Just days before its initial deadline, U.S. regulators say they need more time to decide whether or not to approve Moderna’s respiratory syncytial virus (RSV) vaccine.
Source link
La Potencia Mas Caliente
May 20, 2024
- Trump hush money trial: Judge admonishes defense witness Robert Costello
- Can AI help consumers buy marijuana? A Mass. cannabis delivery firm will find out.
- Dos policías muertos y 50 millones de pesos robados: varios atentados terroristas estremecen al Suroccidente colombiano
- Michael McDonald is ready to get personal in ‘What a Fool Believes’ : NPR
Headlines